P276-00-d4
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
P276-00-d4 Product Information
P276-00-d4 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101016.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
P276-00-d4
CAT No.
CS-T-101016
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C21H16D4ClNO5
Molecular Weight
405.86
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
P276-00-d4 is supplied with detailed characterization data compliant with regulatory guideline. P276-00-d4 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"P276-00-d4 is the labeled analog of P276-00 (P122480), a cyclin-dependent kinase (CDK) inhibitor. P276-00 has shown to be highly selective for cancer cells and has shown to produce potent inhibition of Cdk4-D1 activity. P276-00 also induces apoptosis in human promyelocytic leukemia (HL-60) cells."
Synonyms
P276-00-d4
Application Notes
"P276-00-d4 is the labeled analog of P276-00 (P122480), a cyclin-dependent kinase (CDK) inhibitor. P276-00 has shown to be highly selective for cancer cells and has shown to produce potent inhibition of Cdk4-D1 activity. P276-00 also induces apoptosis in human promyelocytic leukemia (HL-60) cells."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.